Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New epilepsy drug shows promise in real-world italian study

NCT ID NCT05859854

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 31 times

Summary

This study looks at how cenobamate works in adults whose focal seizures are not controlled by at least two other epilepsy drugs. Researchers will track seizure frequency before and during treatment to see if seizures drop by half or more. The goal is to better understand the drug's real-world effectiveness and safety in Italian clinics.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Associazione La Nostra Famiglia - IRCCS Eugenio Medea

    Conegliano, Treviso, 31015, Italy

  • Azienda Sanitaria Universitaria (A.O.U.) Integrata

    Udine, Udine, 33100, Italy

  • Campus Bio-Medico

    Roma, Roma, 00128, Italy

  • Fondazione Istituto Neurologico Casimiro Mondino

    Pavia, Pavia, 27100, Italy

  • Humanitas Gradenigo

    Torino, Torino, 10153, Italy

  • IRCCS Neuromed

    Pozzilli, Isernia, 86077, Italy

  • Ospedale San Bortolo

    Vicenza, Vicenza, 36100, Italy

  • Policlinico Umberto I

    Roma, Roma, 00161, Italy

  • Policlinico di Bari

    Bari, Bari, 70124, Italy

  • Università degli Studi di Catanzaro "Magna Graecia"

    Catanzaro, Catanzaro, 88100, Italy

Conditions

Explore the condition pages connected to this study.